Project
GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for UAUUGCU
Z-value: 0.75
Motif logo
miRNA associated with seed UAUUGCU
| Name | miRBASE accession |
|---|---|
|
hsa-miR-137
|
MIMAT0000429 |
Activity profile of UAUUGCU motif
Sorted Z-values of UAUUGCU motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr2_+_203499901 | 22.41 |
ENST00000303116.6
ENST00000392238.2 |
FAM117B
|
family with sequence similarity 117, member B |
| chr11_-_113746277 | 15.42 |
ENST00000003302.4
ENST00000545540.1 |
USP28
|
ubiquitin specific peptidase 28 |
| chr5_-_131132614 | 15.30 |
ENST00000307968.7
ENST00000307954.8 |
FNIP1
|
folliculin interacting protein 1 |
| chr2_+_113033164 | 14.58 |
ENST00000409871.1
ENST00000343936.4 |
ZC3H6
|
zinc finger CCCH-type containing 6 |
| chr11_-_117747607 | 10.50 |
ENST00000540359.1
ENST00000539526.1 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
| chr7_-_139876812 | 9.84 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
| chr11_+_92085262 | 9.26 |
ENST00000298047.6
ENST00000409404.2 ENST00000541502.1 |
FAT3
|
FAT atypical cadherin 3 |
| chr5_-_172198190 | 8.91 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
| chr22_+_41777927 | 8.86 |
ENST00000266304.4
|
TEF
|
thyrotrophic embryonic factor |
| chr7_+_138916231 | 8.48 |
ENST00000473989.3
ENST00000288561.8 |
UBN2
|
ubinuclein 2 |
| chr19_+_1205740 | 8.46 |
ENST00000326873.7
|
STK11
|
serine/threonine kinase 11 |
| chr20_+_54933971 | 8.33 |
ENST00000371384.3
ENST00000437418.1 |
FAM210B
|
family with sequence similarity 210, member B |
| chr8_+_142402089 | 8.31 |
ENST00000521578.1
ENST00000520105.1 ENST00000523147.1 |
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3 |
| chr7_-_35734730 | 8.27 |
ENST00000396081.1
ENST00000311350.3 |
HERPUD2
|
HERPUD family member 2 |
| chr1_+_44115814 | 8.25 |
ENST00000372396.3
|
KDM4A
|
lysine (K)-specific demethylase 4A |
| chrX_+_128913906 | 8.21 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
| chr4_+_7045042 | 8.21 |
ENST00000310074.7
ENST00000512388.1 |
TADA2B
|
transcriptional adaptor 2B |
| chr11_-_18656028 | 8.09 |
ENST00000336349.5
|
SPTY2D1
|
SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae) |
| chr2_-_43453734 | 7.95 |
ENST00000282388.3
|
ZFP36L2
|
ZFP36 ring finger protein-like 2 |
| chr7_-_44924939 | 7.80 |
ENST00000395699.2
|
PURB
|
purine-rich element binding protein B |
| chr17_-_1532106 | 7.75 |
ENST00000301335.5
ENST00000382147.4 |
SLC43A2
|
solute carrier family 43 (amino acid system L transporter), member 2 |
| chr14_-_45431091 | 7.65 |
ENST00000579157.1
ENST00000396128.4 ENST00000556500.1 |
KLHL28
|
kelch-like family member 28 |
| chr2_-_37193606 | 7.54 |
ENST00000379213.2
ENST00000263918.4 |
STRN
|
striatin, calmodulin binding protein |
| chr11_+_121322832 | 7.43 |
ENST00000260197.7
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
| chr2_-_201936302 | 7.34 |
ENST00000453765.1
ENST00000452799.1 ENST00000446678.1 ENST00000418596.3 |
FAM126B
|
family with sequence similarity 126, member B |
| chr2_+_10183651 | 7.09 |
ENST00000305883.1
|
KLF11
|
Kruppel-like factor 11 |
| chr14_+_93389425 | 7.00 |
ENST00000216492.5
ENST00000334654.4 |
CHGA
|
chromogranin A (parathyroid secretory protein 1) |
| chr12_+_120105558 | 6.64 |
ENST00000229328.5
ENST00000541640.1 |
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
| chr9_-_93405352 | 6.53 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
| chr1_+_236849754 | 6.52 |
ENST00000542672.1
ENST00000366578.4 |
ACTN2
|
actinin, alpha 2 |
| chrX_+_110339439 | 6.51 |
ENST00000372010.1
ENST00000519681.1 ENST00000372007.5 |
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3 |
| chr2_+_70142189 | 6.48 |
ENST00000264444.2
|
MXD1
|
MAX dimerization protein 1 |
| chr19_-_11591848 | 6.44 |
ENST00000359227.3
|
ELAVL3
|
ELAV like neuron-specific RNA binding protein 3 |
| chr6_+_106546808 | 6.31 |
ENST00000369089.3
|
PRDM1
|
PR domain containing 1, with ZNF domain |
| chr18_+_9136758 | 6.29 |
ENST00000383440.2
ENST00000262126.4 ENST00000577992.1 |
ANKRD12
|
ankyrin repeat domain 12 |
| chr19_+_4007644 | 6.22 |
ENST00000262971.2
|
PIAS4
|
protein inhibitor of activated STAT, 4 |
| chr12_+_69864129 | 6.21 |
ENST00000547219.1
ENST00000299293.2 ENST00000549921.1 ENST00000550316.1 ENST00000548154.1 ENST00000547414.1 ENST00000550389.1 ENST00000550937.1 ENST00000549092.1 ENST00000550169.1 |
FRS2
|
fibroblast growth factor receptor substrate 2 |
| chr7_+_106685079 | 6.21 |
ENST00000265717.4
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta |
| chr20_+_37434329 | 6.15 |
ENST00000299824.1
ENST00000373331.2 |
PPP1R16B
|
protein phosphatase 1, regulatory subunit 16B |
| chr3_-_21792838 | 6.11 |
ENST00000281523.2
|
ZNF385D
|
zinc finger protein 385D |
| chr16_-_2264779 | 6.02 |
ENST00000333503.7
|
PGP
|
phosphoglycolate phosphatase |
| chr12_-_42538657 | 5.94 |
ENST00000398675.3
|
GXYLT1
|
glucoside xylosyltransferase 1 |
| chr14_-_100070363 | 5.94 |
ENST00000380243.4
|
CCDC85C
|
coiled-coil domain containing 85C |
| chr7_-_122526799 | 5.91 |
ENST00000334010.7
ENST00000313070.7 |
CADPS2
|
Ca++-dependent secretion activator 2 |
| chr4_-_153457197 | 5.81 |
ENST00000281708.4
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
| chr12_+_54402790 | 5.79 |
ENST00000040584.4
|
HOXC8
|
homeobox C8 |
| chr14_+_65171099 | 5.77 |
ENST00000247226.7
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
| chr14_+_73704201 | 5.71 |
ENST00000340738.5
ENST00000427855.1 ENST00000381166.3 |
PAPLN
|
papilin, proteoglycan-like sulfated glycoprotein |
| chr2_-_25475120 | 5.71 |
ENST00000380746.4
ENST00000402667.1 |
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha |
| chr6_-_91006461 | 5.70 |
ENST00000257749.4
ENST00000343122.3 ENST00000406998.2 ENST00000453877.1 |
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
| chr12_-_111021110 | 5.69 |
ENST00000354300.3
|
PPTC7
|
PTC7 protein phosphatase homolog (S. cerevisiae) |
| chr3_+_49591881 | 5.65 |
ENST00000296452.4
|
BSN
|
bassoon presynaptic cytomatrix protein |
| chr16_+_1203194 | 5.63 |
ENST00000348261.5
ENST00000358590.4 |
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
| chr19_+_35521572 | 5.63 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chr6_+_56954867 | 5.60 |
ENST00000370708.4
ENST00000370702.1 |
ZNF451
|
zinc finger protein 451 |
| chr12_+_123319973 | 5.58 |
ENST00000253083.4
|
HIP1R
|
huntingtin interacting protein 1 related |
| chr1_-_31712401 | 5.56 |
ENST00000373736.2
|
NKAIN1
|
Na+/K+ transporting ATPase interacting 1 |
| chr20_+_44657845 | 5.47 |
ENST00000243964.3
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
| chr19_+_35759824 | 5.45 |
ENST00000343550.5
|
USF2
|
upstream transcription factor 2, c-fos interacting |
| chr11_+_128563652 | 5.43 |
ENST00000527786.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
| chr22_+_29876197 | 5.35 |
ENST00000310624.6
|
NEFH
|
neurofilament, heavy polypeptide |
| chr15_-_58358607 | 5.35 |
ENST00000249750.4
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2 |
| chr4_-_90229142 | 5.33 |
ENST00000609438.1
|
GPRIN3
|
GPRIN family member 3 |
| chrX_-_40594755 | 5.31 |
ENST00000324817.1
|
MED14
|
mediator complex subunit 14 |
| chr17_-_4046257 | 5.25 |
ENST00000381638.2
|
ZZEF1
|
zinc finger, ZZ-type with EF-hand domain 1 |
| chr18_-_74207146 | 5.24 |
ENST00000443185.2
|
ZNF516
|
zinc finger protein 516 |
| chr5_-_65017921 | 5.20 |
ENST00000381007.4
|
SGTB
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta |
| chr19_+_589893 | 5.16 |
ENST00000251287.2
|
HCN2
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 2 |
| chr9_-_123476719 | 5.11 |
ENST00000373930.3
|
MEGF9
|
multiple EGF-like-domains 9 |
| chr5_-_93447333 | 5.10 |
ENST00000395965.3
ENST00000505869.1 ENST00000509163.1 |
FAM172A
|
family with sequence similarity 172, member A |
| chr13_-_21476900 | 5.08 |
ENST00000400602.2
ENST00000255305.6 |
XPO4
|
exportin 4 |
| chr4_+_48018781 | 5.03 |
ENST00000295461.5
|
NIPAL1
|
NIPA-like domain containing 1 |
| chr20_-_42939782 | 5.00 |
ENST00000396825.3
|
FITM2
|
fat storage-inducing transmembrane protein 2 |
| chr9_-_91793675 | 4.97 |
ENST00000375835.4
ENST00000375830.1 |
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3 |
| chr11_-_64570706 | 4.96 |
ENST00000294066.2
ENST00000377350.3 |
MAP4K2
|
mitogen-activated protein kinase kinase kinase kinase 2 |
| chr20_+_24449821 | 4.93 |
ENST00000376862.3
|
SYNDIG1
|
synapse differentiation inducing 1 |
| chr6_-_46293378 | 4.91 |
ENST00000330430.6
|
RCAN2
|
regulator of calcineurin 2 |
| chr21_+_45285050 | 4.89 |
ENST00000291572.8
|
AGPAT3
|
1-acylglycerol-3-phosphate O-acyltransferase 3 |
| chr15_+_65134088 | 4.88 |
ENST00000323544.4
ENST00000437723.1 |
PLEKHO2
AC069368.3
|
pleckstrin homology domain containing, family O member 2 Uncharacterized protein |
| chr11_-_66336060 | 4.87 |
ENST00000310325.5
|
CTSF
|
cathepsin F |
| chr4_+_78078304 | 4.85 |
ENST00000316355.5
ENST00000354403.5 ENST00000502280.1 |
CCNG2
|
cyclin G2 |
| chr5_+_49961727 | 4.74 |
ENST00000505697.2
ENST00000503750.2 ENST00000514342.2 |
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
| chr14_+_74111578 | 4.73 |
ENST00000554113.1
ENST00000555631.2 ENST00000553645.2 ENST00000311089.3 ENST00000555919.3 ENST00000554339.1 ENST00000554871.1 |
DNAL1
|
dynein, axonemal, light chain 1 |
| chrX_+_21857717 | 4.72 |
ENST00000379484.5
|
MBTPS2
|
membrane-bound transcription factor peptidase, site 2 |
| chr4_+_55524085 | 4.67 |
ENST00000412167.2
ENST00000288135.5 |
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
| chr1_+_220701456 | 4.64 |
ENST00000366918.4
ENST00000402574.1 |
MARK1
|
MAP/microtubule affinity-regulating kinase 1 |
| chr1_-_38471156 | 4.63 |
ENST00000373016.3
|
FHL3
|
four and a half LIM domains 3 |
| chr1_+_95582881 | 4.62 |
ENST00000370203.4
ENST00000456991.1 |
TMEM56
|
transmembrane protein 56 |
| chr15_-_34628951 | 4.62 |
ENST00000397707.2
ENST00000560611.1 |
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
| chr14_-_99737565 | 4.60 |
ENST00000357195.3
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein) |
| chr5_+_56111361 | 4.59 |
ENST00000399503.3
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
| chr9_-_139440314 | 4.52 |
ENST00000277541.6
|
NOTCH1
|
notch 1 |
| chr11_-_1593150 | 4.51 |
ENST00000397374.3
|
DUSP8
|
dual specificity phosphatase 8 |
| chr7_-_105029329 | 4.44 |
ENST00000393651.3
ENST00000460391.1 |
SRPK2
|
SRSF protein kinase 2 |
| chr5_+_79331164 | 4.43 |
ENST00000350881.2
|
THBS4
|
thrombospondin 4 |
| chr7_+_119913688 | 4.40 |
ENST00000331113.4
|
KCND2
|
potassium voltage-gated channel, Shal-related subfamily, member 2 |
| chr17_-_19771216 | 4.40 |
ENST00000395544.4
|
ULK2
|
unc-51 like autophagy activating kinase 2 |
| chr2_-_9143786 | 4.37 |
ENST00000462696.1
ENST00000305997.3 |
MBOAT2
|
membrane bound O-acyltransferase domain containing 2 |
| chr16_+_11762270 | 4.35 |
ENST00000329565.5
|
SNN
|
stannin |
| chr2_+_173940442 | 4.32 |
ENST00000409176.2
ENST00000338983.3 ENST00000431503.2 |
MLTK
|
Mitogen-activated protein kinase kinase kinase MLT |
| chr11_-_119599794 | 4.29 |
ENST00000264025.3
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
| chr11_-_45687128 | 4.29 |
ENST00000308064.2
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
| chr12_+_113659234 | 4.29 |
ENST00000551096.1
ENST00000551099.1 ENST00000335509.6 ENST00000552897.1 ENST00000550785.1 ENST00000549279.1 |
TPCN1
|
two pore segment channel 1 |
| chr1_+_90460661 | 4.27 |
ENST00000340281.4
ENST00000361911.5 ENST00000370447.3 ENST00000455342.2 |
ZNF326
|
zinc finger protein 326 |
| chr15_-_26108355 | 4.25 |
ENST00000356865.6
|
ATP10A
|
ATPase, class V, type 10A |
| chr1_-_72748417 | 4.19 |
ENST00000357731.5
|
NEGR1
|
neuronal growth regulator 1 |
| chr18_-_53255766 | 4.19 |
ENST00000566286.1
ENST00000564999.1 ENST00000566279.1 ENST00000354452.3 ENST00000356073.4 |
TCF4
|
transcription factor 4 |
| chr5_+_161274685 | 4.19 |
ENST00000428797.2
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
| chr15_-_61521495 | 4.16 |
ENST00000335670.6
|
RORA
|
RAR-related orphan receptor A |
| chr16_+_68056844 | 4.13 |
ENST00000565263.1
|
DUS2
|
dihydrouridine synthase 2 |
| chr12_+_55413721 | 4.11 |
ENST00000242994.3
|
NEUROD4
|
neuronal differentiation 4 |
| chr11_+_24518723 | 4.10 |
ENST00000336930.6
ENST00000529015.1 ENST00000533227.1 |
LUZP2
|
leucine zipper protein 2 |
| chr4_+_89513574 | 4.09 |
ENST00000402738.1
ENST00000431413.1 ENST00000422770.1 ENST00000407637.1 |
HERC3
|
HECT and RLD domain containing E3 ubiquitin protein ligase 3 |
| chr12_+_5019061 | 4.05 |
ENST00000382545.3
|
KCNA1
|
potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) |
| chr14_-_81687197 | 4.03 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
| chr12_-_53074182 | 4.02 |
ENST00000252244.3
|
KRT1
|
keratin 1 |
| chr10_-_73848531 | 3.97 |
ENST00000373109.2
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
| chr19_+_1286097 | 3.97 |
ENST00000215368.2
|
EFNA2
|
ephrin-A2 |
| chr19_+_16435625 | 3.96 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
| chr1_-_118472216 | 3.95 |
ENST00000369443.5
|
GDAP2
|
ganglioside induced differentiation associated protein 2 |
| chr11_-_62359027 | 3.93 |
ENST00000494385.1
ENST00000308436.7 |
TUT1
|
terminal uridylyl transferase 1, U6 snRNA-specific |
| chr3_+_47021168 | 3.87 |
ENST00000450053.3
ENST00000292309.5 ENST00000383740.2 |
NBEAL2
|
neurobeachin-like 2 |
| chr10_-_53459319 | 3.86 |
ENST00000331173.4
|
CSTF2T
|
cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, tau variant |
| chr16_+_66878814 | 3.85 |
ENST00000394069.3
|
CA7
|
carbonic anhydrase VII |
| chr11_-_73309228 | 3.84 |
ENST00000356467.4
ENST00000064778.4 |
FAM168A
|
family with sequence similarity 168, member A |
| chr3_+_11034403 | 3.83 |
ENST00000287766.4
ENST00000425938.1 |
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1 |
| chr13_-_29292956 | 3.82 |
ENST00000266943.6
|
SLC46A3
|
solute carrier family 46, member 3 |
| chr9_-_101471479 | 3.81 |
ENST00000259455.2
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
| chr3_+_43328004 | 3.78 |
ENST00000454177.1
ENST00000429705.2 ENST00000296088.7 ENST00000437827.1 |
SNRK
|
SNF related kinase |
| chr22_+_41956767 | 3.77 |
ENST00000306149.7
|
CSDC2
|
cold shock domain containing C2, RNA binding |
| chr6_-_8064567 | 3.77 |
ENST00000543936.1
ENST00000397457.2 |
BLOC1S5
|
biogenesis of lysosomal organelles complex-1, subunit 5, muted |
| chr10_-_102989551 | 3.77 |
ENST00000370193.2
|
LBX1
|
ladybird homeobox 1 |
| chr10_+_180987 | 3.76 |
ENST00000381591.1
|
ZMYND11
|
zinc finger, MYND-type containing 11 |
| chr7_+_4721885 | 3.75 |
ENST00000328914.4
|
FOXK1
|
forkhead box K1 |
| chr17_+_12692774 | 3.75 |
ENST00000379672.5
ENST00000340825.3 |
ARHGAP44
|
Rho GTPase activating protein 44 |
| chr7_+_76090993 | 3.75 |
ENST00000425780.1
ENST00000456590.1 ENST00000451769.1 ENST00000324432.5 ENST00000307569.8 ENST00000457529.1 ENST00000446600.1 ENST00000413936.2 ENST00000423646.1 ENST00000438930.1 ENST00000430490.2 |
DTX2
|
deltex homolog 2 (Drosophila) |
| chr17_-_74236382 | 3.74 |
ENST00000592271.1
ENST00000319945.6 ENST00000269391.6 |
RNF157
|
ring finger protein 157 |
| chr20_+_35974532 | 3.72 |
ENST00000373578.2
|
SRC
|
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog |
| chr12_-_120806960 | 3.69 |
ENST00000257552.2
|
MSI1
|
musashi RNA-binding protein 1 |
| chr7_-_6866401 | 3.66 |
ENST00000316731.8
|
CCZ1B
|
CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae) |
| chr5_+_152870106 | 3.63 |
ENST00000285900.5
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1 |
| chr5_-_81046922 | 3.63 |
ENST00000514493.1
ENST00000320672.4 |
SSBP2
|
single-stranded DNA binding protein 2 |
| chr17_-_42580738 | 3.62 |
ENST00000585614.1
ENST00000591680.1 ENST00000434000.1 ENST00000588554.1 ENST00000592154.1 |
GPATCH8
|
G patch domain containing 8 |
| chr12_+_56401268 | 3.62 |
ENST00000262032.5
|
IKZF4
|
IKAROS family zinc finger 4 (Eos) |
| chr1_-_211307315 | 3.60 |
ENST00000271751.4
|
KCNH1
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
| chr19_-_4066890 | 3.59 |
ENST00000322357.4
|
ZBTB7A
|
zinc finger and BTB domain containing 7A |
| chr10_+_115803650 | 3.55 |
ENST00000369295.2
|
ADRB1
|
adrenoceptor beta 1 |
| chrX_-_154033793 | 3.54 |
ENST00000369534.3
ENST00000413259.3 |
MPP1
|
membrane protein, palmitoylated 1, 55kDa |
| chr7_+_21467642 | 3.52 |
ENST00000222584.3
ENST00000432066.2 |
SP4
|
Sp4 transcription factor |
| chr12_-_49504655 | 3.52 |
ENST00000551782.1
ENST00000267102.8 |
LMBR1L
|
limb development membrane protein 1-like |
| chr9_+_136325089 | 3.51 |
ENST00000291722.7
ENST00000316948.4 ENST00000540581.1 |
CACFD1
|
calcium channel flower domain containing 1 |
| chr2_+_176972000 | 3.49 |
ENST00000249504.5
|
HOXD11
|
homeobox D11 |
| chr2_-_182545603 | 3.44 |
ENST00000295108.3
|
NEUROD1
|
neuronal differentiation 1 |
| chr18_+_43753974 | 3.44 |
ENST00000282059.6
ENST00000321319.6 |
C18orf25
|
chromosome 18 open reading frame 25 |
| chr14_+_103851712 | 3.43 |
ENST00000440884.3
ENST00000416682.2 ENST00000429436.2 ENST00000303622.9 |
MARK3
|
MAP/microtubule affinity-regulating kinase 3 |
| chr16_+_11038345 | 3.42 |
ENST00000409790.1
|
CLEC16A
|
C-type lectin domain family 16, member A |
| chr3_+_29322803 | 3.39 |
ENST00000396583.3
ENST00000383767.2 |
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
| chr7_-_44530479 | 3.38 |
ENST00000355451.7
|
NUDCD3
|
NudC domain containing 3 |
| chr5_-_176326333 | 3.36 |
ENST00000292432.5
|
HK3
|
hexokinase 3 (white cell) |
| chr6_+_35227449 | 3.34 |
ENST00000373953.3
ENST00000440666.2 ENST00000339411.5 |
ZNF76
|
zinc finger protein 76 |
| chr14_-_24911971 | 3.33 |
ENST00000555365.1
ENST00000399395.3 |
SDR39U1
|
short chain dehydrogenase/reductase family 39U, member 1 |
| chr19_+_45596218 | 3.32 |
ENST00000421905.1
ENST00000221462.4 |
PPP1R37
|
protein phosphatase 1, regulatory subunit 37 |
| chr3_-_114790179 | 3.32 |
ENST00000462705.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
| chr3_+_37493610 | 3.30 |
ENST00000264741.5
|
ITGA9
|
integrin, alpha 9 |
| chr12_+_2162447 | 3.29 |
ENST00000335762.5
ENST00000399655.1 |
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
| chr1_+_213123915 | 3.22 |
ENST00000366968.4
ENST00000490792.1 |
VASH2
|
vasohibin 2 |
| chr10_-_15762124 | 3.21 |
ENST00000378076.3
|
ITGA8
|
integrin, alpha 8 |
| chr15_+_79724858 | 3.21 |
ENST00000305428.3
|
KIAA1024
|
KIAA1024 |
| chr7_+_155250824 | 3.21 |
ENST00000297375.4
|
EN2
|
engrailed homeobox 2 |
| chr18_+_13218769 | 3.17 |
ENST00000399848.3
ENST00000361205.4 |
LDLRAD4
|
low density lipoprotein receptor class A domain containing 4 |
| chr15_-_55881135 | 3.17 |
ENST00000302000.6
|
PYGO1
|
pygopus family PHD finger 1 |
| chr19_-_8642289 | 3.17 |
ENST00000596675.1
ENST00000338257.8 |
MYO1F
|
myosin IF |
| chr11_-_790060 | 3.17 |
ENST00000330106.4
|
CEND1
|
cell cycle exit and neuronal differentiation 1 |
| chr3_+_178276488 | 3.17 |
ENST00000432997.1
ENST00000455865.1 |
KCNMB2
|
potassium large conductance calcium-activated channel, subfamily M, beta member 2 |
| chr12_-_54121212 | 3.14 |
ENST00000548263.1
ENST00000430117.2 ENST00000550804.1 ENST00000549173.1 ENST00000551900.1 ENST00000546619.1 ENST00000548177.1 ENST00000549349.1 |
CALCOCO1
|
calcium binding and coiled-coil domain 1 |
| chr10_+_101419187 | 3.14 |
ENST00000370489.4
|
ENTPD7
|
ectonucleoside triphosphate diphosphohydrolase 7 |
| chr1_-_111150048 | 3.13 |
ENST00000485317.1
|
KCNA2
|
potassium voltage-gated channel, shaker-related subfamily, member 2 |
| chr19_-_45663408 | 3.10 |
ENST00000317951.4
|
NKPD1
|
NTPase, KAP family P-loop domain containing 1 |
| chr13_+_23755054 | 3.08 |
ENST00000218867.3
|
SGCG
|
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) |
| chr5_+_7396141 | 3.06 |
ENST00000338316.4
|
ADCY2
|
adenylate cyclase 2 (brain) |
| chr5_-_131347306 | 3.04 |
ENST00000296869.4
ENST00000379249.3 ENST00000379272.2 ENST00000379264.2 |
ACSL6
|
acyl-CoA synthetase long-chain family member 6 |
| chrX_+_118108571 | 3.03 |
ENST00000304778.7
|
LONRF3
|
LON peptidase N-terminal domain and ring finger 3 |
| chr22_+_50781723 | 3.03 |
ENST00000359139.3
ENST00000395741.3 ENST00000395744.3 |
PPP6R2
|
protein phosphatase 6, regulatory subunit 2 |
| chr12_+_104458235 | 3.00 |
ENST00000229330.4
|
HCFC2
|
host cell factor C2 |
| chr9_-_110251836 | 2.99 |
ENST00000374672.4
|
KLF4
|
Kruppel-like factor 4 (gut) |
| chr17_+_53342311 | 2.99 |
ENST00000226067.5
|
HLF
|
hepatic leukemia factor |
| chr2_+_166095898 | 2.97 |
ENST00000424833.1
ENST00000375437.2 ENST00000357398.3 |
SCN2A
|
sodium channel, voltage-gated, type II, alpha subunit |
| chr4_-_141348999 | 2.95 |
ENST00000325617.5
|
CLGN
|
calmegin |
| chr5_+_149109825 | 2.93 |
ENST00000360453.4
ENST00000394320.3 ENST00000309241.5 |
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta |
| chr3_-_69101413 | 2.93 |
ENST00000398559.2
|
TMF1
|
TATA element modulatory factor 1 |
| chrX_+_153686614 | 2.93 |
ENST00000369682.3
|
PLXNA3
|
plexin A3 |
| chr14_+_71108460 | 2.93 |
ENST00000256367.2
|
TTC9
|
tetratricopeptide repeat domain 9 |
| chr2_+_86947296 | 2.92 |
ENST00000283632.4
|
RMND5A
|
required for meiotic nuclear division 5 homolog A (S. cerevisiae) |
| chr18_-_44497308 | 2.91 |
ENST00000585916.1
ENST00000324794.7 ENST00000545673.1 |
PIAS2
|
protein inhibitor of activated STAT, 2 |
| chr20_+_32077880 | 2.91 |
ENST00000342704.6
ENST00000375279.2 |
CBFA2T2
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 2 |
| chr10_-_94003003 | 2.89 |
ENST00000412050.4
|
CPEB3
|
cytoplasmic polyadenylation element binding protein 3 |
| chr15_-_45815005 | 2.88 |
ENST00000261867.4
|
SLC30A4
|
solute carrier family 30 (zinc transporter), member 4 |
| chr11_-_132813566 | 2.88 |
ENST00000331898.7
|
OPCML
|
opioid binding protein/cell adhesion molecule-like |
| chr12_+_79258547 | 2.86 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
| chr1_-_41131326 | 2.85 |
ENST00000372684.3
|
RIMS3
|
regulating synaptic membrane exocytosis 3 |
Network of associatons between targets according to the STRING database.
First level regulatory network of UAUUGCU
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.8 | 15.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 3.0 | 9.0 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 3.0 | 8.9 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 2.9 | 5.8 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 2.5 | 7.4 | GO:1902997 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 2.3 | 7.0 | GO:0061110 | dense core granule biogenesis(GO:0061110) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
| 2.1 | 6.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 1.9 | 5.6 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 1.9 | 5.6 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 1.8 | 5.3 | GO:0048936 | neurofilament bundle assembly(GO:0033693) peripheral nervous system neuron axonogenesis(GO:0048936) |
| 1.6 | 6.5 | GO:2001137 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) positive regulation of endocytic recycling(GO:2001137) |
| 1.6 | 4.7 | GO:0048170 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) erythropoietin-mediated signaling pathway(GO:0038162) positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 1.5 | 6.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 1.4 | 5.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 1.4 | 5.5 | GO:0019086 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) late viral transcription(GO:0019086) |
| 1.3 | 8.0 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 1.3 | 9.3 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 1.3 | 7.9 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 1.3 | 2.5 | GO:2000364 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 1.3 | 6.3 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
| 1.2 | 6.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 1.2 | 6.2 | GO:0097338 | response to clozapine(GO:0097338) |
| 1.2 | 1.2 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
| 1.2 | 3.6 | GO:0003099 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 1.2 | 5.8 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 1.2 | 4.6 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 1.1 | 4.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 1.1 | 8.0 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 1.1 | 8.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 1.0 | 8.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 1.0 | 8.3 | GO:1900113 | histone H3-K36 demethylation(GO:0070544) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 1.0 | 5.9 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 1.0 | 1.0 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 1.0 | 2.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 1.0 | 3.8 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 1.0 | 2.9 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 1.0 | 5.7 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.9 | 7.5 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.9 | 8.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.9 | 2.7 | GO:1903970 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 0.9 | 4.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.9 | 4.4 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.8 | 1.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.8 | 2.4 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.8 | 2.4 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.8 | 3.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 0.8 | 3.1 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.8 | 3.9 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 0.7 | 1.5 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.7 | 5.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.7 | 7.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.7 | 2.8 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) regulation of cellular response to drug(GO:2001038) |
| 0.7 | 4.1 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.7 | 3.4 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
| 0.7 | 2.0 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.7 | 5.3 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.7 | 2.6 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.6 | 4.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.6 | 3.2 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.6 | 2.5 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.6 | 5.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.6 | 5.6 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
| 0.6 | 1.9 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.6 | 2.9 | GO:2000843 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.6 | 4.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.6 | 2.9 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.6 | 2.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.6 | 2.2 | GO:0042631 | cellular response to water deprivation(GO:0042631) cellular response to mercury ion(GO:0071288) |
| 0.6 | 2.8 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.5 | 4.9 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.5 | 1.6 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.5 | 1.6 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.5 | 1.6 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.5 | 1.6 | GO:0021764 | amygdala development(GO:0021764) |
| 0.5 | 1.6 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.5 | 1.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 0.5 | 4.1 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.5 | 3.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.5 | 2.0 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.5 | 3.0 | GO:1903960 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) |
| 0.5 | 7.0 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
| 0.5 | 8.9 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.5 | 2.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.5 | 6.6 | GO:0035878 | nail development(GO:0035878) |
| 0.5 | 2.8 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.4 | 8.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
| 0.4 | 2.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.4 | 2.1 | GO:0086053 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.4 | 2.1 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.4 | 1.6 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.4 | 1.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.4 | 2.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.4 | 3.9 | GO:0032526 | response to retinoic acid(GO:0032526) |
| 0.4 | 4.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.4 | 1.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.4 | 2.7 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.4 | 1.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 0.4 | 2.3 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.4 | 0.8 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.4 | 1.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.4 | 3.0 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.4 | 4.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.4 | 3.2 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.4 | 2.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.4 | 2.8 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.3 | 2.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.3 | 4.2 | GO:0021930 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.3 | 3.8 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.3 | 1.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.3 | 2.0 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.3 | 3.0 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
| 0.3 | 1.3 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.3 | 2.3 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
| 0.3 | 2.6 | GO:0097107 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.3 | 2.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.3 | 4.9 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.3 | 6.4 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.3 | 4.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.3 | 2.8 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.3 | 0.9 | GO:0061010 | gall bladder development(GO:0061010) |
| 0.3 | 2.5 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.3 | 4.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.3 | 0.9 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.3 | 2.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.3 | 1.5 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.3 | 0.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.3 | 2.9 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.3 | 2.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.3 | 1.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 0.3 | 0.6 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
| 0.3 | 1.9 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.3 | 0.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 0.3 | 10.9 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
| 0.3 | 0.5 | GO:0090245 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) axis elongation involved in somitogenesis(GO:0090245) |
| 0.3 | 0.8 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.3 | 3.8 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
| 0.3 | 0.8 | GO:0032900 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) negative regulation of neurotrophin production(GO:0032900) |
| 0.3 | 3.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.3 | 5.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.3 | 2.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.3 | 2.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.3 | 10.6 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.3 | 1.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.3 | 3.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.3 | 4.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.3 | 1.3 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.2 | 2.2 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
| 0.2 | 2.6 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.2 | 2.3 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.2 | 1.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.2 | 4.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.2 | 0.2 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) regulation of AV node cell action potential(GO:0098904) regulation of SA node cell action potential(GO:0098907) |
| 0.2 | 2.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 | 6.0 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.2 | 5.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.2 | 1.7 | GO:0042428 | serotonin metabolic process(GO:0042428) |
| 0.2 | 9.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.2 | 1.5 | GO:0042426 | choline catabolic process(GO:0042426) |
| 0.2 | 1.7 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.2 | 2.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.2 | 4.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.2 | 4.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 1.4 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 | 1.8 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.2 | 8.4 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.2 | 1.8 | GO:0099624 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.2 | 3.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.2 | 3.1 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.2 | 2.9 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.2 | 3.9 | GO:0030220 | platelet formation(GO:0030220) |
| 0.2 | 0.8 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 0.2 | 4.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 | 2.6 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 | 3.2 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.2 | 1.5 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.2 | 0.9 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.2 | 1.6 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.2 | 10.5 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.2 | 1.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.2 | 13.1 | GO:0034644 | cellular response to UV(GO:0034644) |
| 0.2 | 1.7 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
| 0.2 | 2.9 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.2 | 3.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.2 | 2.5 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.2 | 1.0 | GO:0060013 | righting reflex(GO:0060013) |
| 0.2 | 3.8 | GO:0007616 | long-term memory(GO:0007616) |
| 0.2 | 0.9 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 | 4.4 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 | 0.4 | GO:0021569 | rhombomere 3 development(GO:0021569) rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.1 | 5.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 | 0.6 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 | 1.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 3.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 | 3.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.1 | 2.6 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.1 | 2.0 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 | 0.3 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.1 | 2.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 | 3.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
| 0.1 | 0.9 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.1 | 3.2 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
| 0.1 | 1.6 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.1 | 5.5 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.1 | 0.6 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.1 | 0.9 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 1.3 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.1 | 2.3 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.1 | 0.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.1 | 1.0 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 | 0.3 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.1 | 2.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 | 4.7 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 0.1 | 2.6 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
| 0.1 | 3.8 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.1 | 3.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.1 | 2.3 | GO:0021772 | olfactory bulb development(GO:0021772) |
| 0.1 | 2.9 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 | 4.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.1 | 3.2 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.1 | 7.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.1 | 0.7 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 | 3.5 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.1 | 2.5 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.1 | 2.4 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.1 | 2.2 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 | 0.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.1 | 1.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 1.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 | 1.2 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 | 3.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.1 | 0.4 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 0.1 | 0.8 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.1 | 0.7 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.1 | 0.1 | GO:0060601 | prostatic bud formation(GO:0060513) lateral sprouting from an epithelium(GO:0060601) regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
| 0.1 | 0.5 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.1 | 0.8 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.1 | 0.6 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.1 | 2.3 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
| 0.1 | 1.0 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 | 2.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.1 | 3.1 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.1 | 2.2 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 | 0.3 | GO:0003157 | endocardium development(GO:0003157) |
| 0.1 | 0.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 | 1.7 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.1 | 2.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 | 0.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.1 | 1.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 | 1.2 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 | 2.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.1 | 3.5 | GO:0098727 | maintenance of cell number(GO:0098727) |
| 0.1 | 1.5 | GO:0051262 | protein tetramerization(GO:0051262) |
| 0.1 | 0.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.1 | 0.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 2.4 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
| 0.1 | 5.3 | GO:0009952 | anterior/posterior pattern specification(GO:0009952) |
| 0.0 | 0.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 | 3.6 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 | 2.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.0 | 0.7 | GO:0007507 | heart development(GO:0007507) |
| 0.0 | 0.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 | 0.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.0 | 2.2 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
| 0.0 | 1.4 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.0 | 3.2 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 | 1.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 | 1.4 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.0 | 0.9 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.0 | 0.3 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.0 | 1.4 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.0 | 2.0 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.0 | 5.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 5.4 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
| 0.0 | 2.6 | GO:0007416 | synapse assembly(GO:0007416) |
| 0.0 | 0.1 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.0 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.0 | 1.0 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
| 0.0 | 1.6 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
| 0.0 | 0.6 | GO:0072348 | sulfur compound transport(GO:0072348) |
| 0.0 | 2.8 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
| 0.0 | 4.6 | GO:0045637 | regulation of myeloid cell differentiation(GO:0045637) |
| 0.0 | 0.1 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.0 | 3.1 | GO:0055001 | muscle cell development(GO:0055001) |
| 0.0 | 0.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 | 0.9 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.0 | 0.4 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.0 | 2.2 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.0 | 1.2 | GO:0007612 | learning(GO:0007612) |
| 0.0 | 1.0 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.0 | 0.5 | GO:0018108 | peptidyl-tyrosine phosphorylation(GO:0018108) |
| 0.0 | 1.1 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
| 0.0 | 0.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.0 | 1.4 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.0 | 0.2 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 | 0.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 | 0.2 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.0 | 1.1 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 9.5 | GO:0036398 | TCR signalosome(GO:0036398) |
| 1.4 | 4.3 | GO:0044609 | DBIRD complex(GO:0044609) |
| 1.3 | 3.8 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 1.2 | 1.2 | GO:0030315 | T-tubule(GO:0030315) |
| 1.1 | 3.2 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 1.1 | 5.3 | GO:0070847 | core mediator complex(GO:0070847) |
| 1.0 | 2.9 | GO:0034657 | GID complex(GO:0034657) |
| 1.0 | 2.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.8 | 5.8 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.7 | 3.6 | GO:0044308 | axonal spine(GO:0044308) |
| 0.7 | 2.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.7 | 11.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.6 | 4.7 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.6 | 2.3 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.6 | 2.9 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.6 | 9.0 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.6 | 8.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.5 | 1.6 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.5 | 10.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.5 | 1.6 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
| 0.5 | 2.6 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.5 | 4.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.5 | 6.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.5 | 7.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.5 | 3.9 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.4 | 6.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.4 | 2.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.4 | 6.4 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.4 | 1.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.4 | 10.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.4 | 3.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.4 | 5.7 | GO:0001741 | XY body(GO:0001741) |
| 0.3 | 2.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.3 | 5.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.3 | 0.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.3 | 9.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.3 | 4.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.3 | 1.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.3 | 2.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.3 | 4.1 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.3 | 1.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.3 | 6.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.2 | 1.5 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.2 | 1.7 | GO:0071203 | WASH complex(GO:0071203) |
| 0.2 | 16.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.2 | 15.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.2 | 7.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.2 | 3.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.2 | 0.6 | GO:0031213 | RSF complex(GO:0031213) |
| 0.2 | 9.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.2 | 4.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.2 | 1.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.2 | 1.6 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.2 | 3.4 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.2 | 4.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.2 | 4.0 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.1 | 4.2 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 0.1 | 0.6 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 4.7 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 3.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.1 | 0.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 4.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.1 | 2.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.1 | 1.4 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 5.2 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 2.1 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 0.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 14.3 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 3.6 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 1.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.1 | 8.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 0.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.1 | 1.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.1 | 10.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.1 | 3.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.1 | 4.0 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 1.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.1 | 0.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.1 | 8.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 1.0 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.1 | 8.4 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
| 0.1 | 2.5 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 3.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.1 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.1 | 1.6 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.1 | 4.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.1 | 0.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 1.0 | GO:0043204 | perikaryon(GO:0043204) |
| 0.1 | 3.7 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 7.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 0.2 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.1 | 3.5 | GO:0005844 | polysome(GO:0005844) |
| 0.0 | 2.0 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 2.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 0.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 6.4 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 1.5 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 6.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.0 | 1.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.0 | 1.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 1.9 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 10.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 8.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 2.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.0 | 3.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.0 | 2.4 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 2.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.0 | 3.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 4.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 4.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.0 | 4.1 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.0 | 2.1 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 0.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.0 | 1.4 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 0.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 1.0 | GO:0098793 | presynapse(GO:0098793) |
| 0.0 | 0.1 | GO:0046930 | membrane attack complex(GO:0005579) pore complex(GO:0046930) |
| 0.0 | 3.6 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.0 | 0.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 1.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.8 | 15.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 2.9 | 14.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 2.8 | 8.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 2.1 | 8.4 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 2.1 | 8.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 2.0 | 6.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 1.9 | 5.6 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 1.3 | 5.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 1.3 | 3.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 1.2 | 5.9 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 1.2 | 3.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 1.1 | 2.1 | GO:0086075 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 1.0 | 8.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 1.0 | 3.9 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 1.0 | 7.8 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 1.0 | 5.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 1.0 | 2.9 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.9 | 3.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.9 | 2.8 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.9 | 10.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.9 | 2.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.9 | 2.7 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.8 | 4.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.8 | 10.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.7 | 8.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.7 | 5.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.7 | 7.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.7 | 7.7 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.7 | 4.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.7 | 10.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.6 | 3.8 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.6 | 5.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.6 | 4.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.6 | 1.8 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.6 | 3.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.6 | 3.0 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.6 | 4.2 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.6 | 4.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.6 | 0.6 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.6 | 2.9 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.6 | 4.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.6 | 2.8 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.5 | 4.4 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.5 | 2.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.5 | 7.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.5 | 10.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.5 | 1.6 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.5 | 6.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.5 | 6.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.5 | 2.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.5 | 1.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.5 | 2.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.5 | 2.1 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.5 | 3.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.5 | 3.7 | GO:0071253 | connexin binding(GO:0071253) |
| 0.5 | 7.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.5 | 2.7 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.4 | 2.2 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.4 | 5.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.4 | 1.7 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.4 | 3.4 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.4 | 9.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.4 | 1.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.4 | 5.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.4 | 5.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.3 | 4.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.3 | 5.5 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.3 | 1.0 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 0.3 | 1.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.3 | 8.5 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.3 | 1.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.3 | 4.2 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.3 | 6.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.3 | 2.2 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
| 0.3 | 2.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.3 | 1.6 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.3 | 0.9 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.3 | 1.9 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.3 | 1.8 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.3 | 0.9 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.3 | 2.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.3 | 4.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.3 | 26.8 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 0.3 | 6.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.3 | 4.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.3 | 1.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.2 | 1.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.2 | 1.9 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.2 | 2.6 | GO:0046935 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.2 | 6.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.2 | 4.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.2 | 0.9 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.2 | 5.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.2 | 1.8 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.2 | 5.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.2 | 3.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.2 | 2.3 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.2 | 4.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.2 | 4.8 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.2 | 10.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.2 | 4.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.2 | 1.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.2 | 3.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.2 | 1.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.2 | 2.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.2 | 0.4 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 0.2 | 6.6 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.2 | 10.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.2 | 6.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.2 | 0.8 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.2 | 2.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 1.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.2 | 1.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.2 | 4.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.2 | 2.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.2 | 6.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.2 | 2.6 | GO:0005112 | Notch binding(GO:0005112) |
| 0.2 | 7.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.2 | 2.6 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.2 | 3.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.2 | 1.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.2 | 1.0 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.2 | 5.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.2 | 0.8 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.2 | 4.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.2 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.2 | 4.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.2 | 2.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 1.5 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
| 0.1 | 1.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.1 | 4.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.1 | 0.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.1 | 2.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.1 | 4.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 2.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 3.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 1.0 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 0.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.1 | 9.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.1 | 1.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 2.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 3.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 2.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 11.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 2.1 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
| 0.1 | 3.3 | GO:0043236 | laminin binding(GO:0043236) |
| 0.1 | 0.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.1 | 0.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 1.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 0.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 7.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 3.3 | GO:0061733 | histone acetyltransferase activity(GO:0004402) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
| 0.1 | 1.0 | GO:0019900 | kinase binding(GO:0019900) |
| 0.1 | 0.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.1 | 0.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 2.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 2.7 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.1 | 2.6 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 0.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.1 | 2.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 3.1 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 2.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 1.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 0.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
| 0.0 | 8.1 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.0 | 1.6 | GO:0043621 | protein self-association(GO:0043621) |
| 0.0 | 0.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.0 | 2.3 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 6.0 | GO:0019902 | phosphatase binding(GO:0019902) |
| 0.0 | 0.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.0 | 0.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.0 | 45.8 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.0 | 0.4 | GO:0031432 | titin binding(GO:0031432) |
| 0.0 | 0.6 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
| 0.0 | 1.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.0 | 0.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.0 | 2.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 7.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.3 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.3 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.0 | 1.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
| 0.0 | 0.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.0 | 1.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.0 | 0.8 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
| 0.0 | 0.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 0.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 17.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.3 | 4.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.3 | 7.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.3 | 2.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.3 | 6.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.3 | 8.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.2 | 9.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.2 | 8.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.2 | 4.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.2 | 12.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.2 | 15.6 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.2 | 5.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.2 | 6.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.2 | 4.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 8.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 6.6 | PID MYC PATHWAY | C-MYC pathway |
| 0.1 | 4.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 2.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 5.6 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.1 | 3.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 5.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 2.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.1 | 3.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 2.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 4.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 6.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.1 | 1.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.1 | 1.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 0.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 4.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.1 | 0.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.1 | 2.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 6.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 1.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.1 | 6.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.1 | 5.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 7.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.1 | 7.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 1.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.0 | 1.4 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.0 | 1.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 2.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 0.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 7.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 0.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.0 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 0.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 0.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 19.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.6 | 1.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
| 0.4 | 10.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.4 | 7.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.4 | 5.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.4 | 18.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.4 | 2.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.4 | 6.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.4 | 4.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.3 | 4.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.3 | 10.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.3 | 10.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.3 | 5.6 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.3 | 2.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.3 | 6.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.3 | 6.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 0.3 | 8.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.3 | 4.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.3 | 2.4 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.3 | 3.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 6.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.2 | 4.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.2 | 8.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.2 | 6.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.2 | 4.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.2 | 2.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 3.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.2 | 1.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.2 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.2 | 4.4 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 0.2 | 13.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.2 | 2.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 5.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.1 | 2.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 5.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.1 | 3.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 3.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.1 | 2.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 7.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.1 | 4.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
| 0.1 | 2.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 3.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 2.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 1.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 6.0 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 0.1 | 4.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 6.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 1.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.1 | 2.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 1.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 1.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 2.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.1 | 0.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 7.7 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
| 0.1 | 1.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 2.6 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
| 0.1 | 2.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.0 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 2.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 0.9 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 1.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 0.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.0 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.0 | 2.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 1.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 1.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.0 | 1.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 1.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 1.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.0 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.0 | 1.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |